Elevating Commercialization in China Part 1: The Path to Launch
Available On Demand
May 23, 2023 | 12:00-12:45 PM ET / 18:00-18:45 CET or May 25, 2023 | 16:00 (UTC +8:00)
The pharmaceutical market in China has experienced tremendous growth over the past several decades and is becoming increasingly important. While many life sciences organizations consider China to be a ‘must win’ market, commercial success can be elusive. Despite the large patient base and recent economic and political tailwinds driving the advancement of the healthcare industry, sales for innovative drugs in China are often only a fraction of those in the U.S. The complex and rapidly evolving market dynamics require companies to stay on the cutting edge of new regulatory pathways, pricing/market access and go-to-market models.
Join Trinity Life Sciences’ APAC experts as they explore the key dynamics of the pharmaceutical market in China and uncover multiple strategies and levers that can elevate commercial success in this market.
In this three-part webinar series, our experts will explore:
Part 1: The Path to Launch | May 23rd or 25th
Leveraging novel commercialization pathways for innovative therapies
Part 2: The Key to Pricing & Access Optimization | September (TBA)
Decoding the current dynamics and future trends of Pricing and Market Access
Part 3: The Winning Commercial Model | November (TBA)
Building a model to match China’s changing dynamics
Key Topics Covered In Part 1:
- Regulatory pathways to accelerate commercial launch in China
- Balancing pros and cons
- Insights from recent launches